immune system
• in the bronchoalveolar fluid of mice exposed to intratracheal administration of LPS or Pseudomonas aeruginosa (strain PA103)
• however, lentiviral expression of Sigirr reverses induced-lung inflammation
|
• in the bronchoalveolar fluid of mice exposed to intratracheal administration of LPS or Pseudomonas aeruginosa (strain PA103)
|
• in the bronchoalveolar fluid of mice exposed to intratracheal administration of LPS or Pseudomonas aeruginosa (strain PA103)
• however, lentiviral expression of Sigirr reverses induced-lung inflammation
|
• mice exposed to intratracheal administration of LPS or Pseudomonas aeruginosa (strain PA103) exhibit increased lung infiltration (particularly with neutrophils) and inflammation injury compared with wild-type mice
• however, lentiviral expression of Sigirr reverses induced-lung inflammation
|
• mice exposed to intratracheal administration of LPS or Pseudomonas aeruginosa (strain PA103) exhibit increased lung infiltration (particularly with neutrophils), inflammation injury, and bronchoalveolar fluid levels of TNFalpha, IL1beta, and IL6 release in compared with wild-type mice
• however, lentiviral expression of Sigirr reverses induced-lung inflammation
|
respiratory system
• mice exposed to intratracheal administration of LPS or Pseudomonas aeruginosa (strain PA103) exhibit increased lung infiltration (particularly with neutrophils) and inflammation injury compared with wild-type mice
• however, lentiviral expression of Sigirr reverses induced-lung inflammation
|